In the fourth study, in which L. paracasei, FOS or the combination was administered to HFD-fed mice, the effects on non-alcoholic fatty liver disease (NAFLD) were evaluated [39]. The gene discussed is FOS; the disease is metabolic dysfunction-associated steatotic liver disease.